CN109371167A - Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene - Google Patents
Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene Download PDFInfo
- Publication number
- CN109371167A CN109371167A CN201811320658.5A CN201811320658A CN109371167A CN 109371167 A CN109371167 A CN 109371167A CN 201811320658 A CN201811320658 A CN 201811320658A CN 109371167 A CN109371167 A CN 109371167A
- Authority
- CN
- China
- Prior art keywords
- gene
- genetic elements
- reporter gene
- carrier
- frameshift mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091033409 CRISPR Proteins 0.000 title claims abstract description 79
- 230000002068 genetic effect Effects 0.000 title claims abstract description 53
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 50
- 231100000221 frame shift mutation induction Toxicity 0.000 title claims abstract description 47
- 230000037433 frameshift Effects 0.000 title claims abstract description 47
- 238000005520 cutting process Methods 0.000 title claims abstract description 44
- 238000010362 genome editing Methods 0.000 title claims abstract description 37
- 238000010354 CRISPR gene editing Methods 0.000 title claims abstract description 36
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 58
- 108700008625 Reporter Genes Proteins 0.000 claims abstract description 54
- 108020005004 Guide RNA Proteins 0.000 claims abstract description 45
- 230000014509 gene expression Effects 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 17
- 101150097657 Rest gene Proteins 0.000 claims abstract description 16
- 230000003584 silencer Effects 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 239000003623 enhancer Substances 0.000 claims description 9
- 108010054624 red fluorescent protein Proteins 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 230000029087 digestion Effects 0.000 claims description 7
- 108091005904 Hemoglobin subunit beta Proteins 0.000 claims description 4
- 102100021519 Hemoglobin subunit beta Human genes 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 108091034057 RNA (poly(A)) Proteins 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 abstract description 4
- 210000004027 cell Anatomy 0.000 description 46
- 239000013612 plasmid Substances 0.000 description 31
- 101710115512 Nuclear receptor coactivator 5 Proteins 0.000 description 28
- 102100022932 Nuclear receptor coactivator 5 Human genes 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 25
- 238000003776 cleavage reaction Methods 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000007017 scission Effects 0.000 description 7
- 238000012795 verification Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- 102000037865 fusion proteins Human genes 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000010276 construction Methods 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- MURGITYSBWUQTI-UHFFFAOYSA-N fluorescin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C=C2OC2=CC(O)=CC=C21 MURGITYSBWUQTI-UHFFFAOYSA-N 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108010041986 DNA Vaccines Proteins 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 229940021995 DNA vaccine Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102100028970 HLA class I histocompatibility antigen, alpha chain E Human genes 0.000 description 1
- 108010075704 HLA-A Antigens Proteins 0.000 description 1
- 101150118346 HLA-A gene Proteins 0.000 description 1
- 101000986085 Homo sapiens HLA class I histocompatibility antigen, alpha chain E Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002304 esc Anatomy 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/10—Vectors comprising a non-peptidic targeting moiety
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of Genetic elements and applications that frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene.The Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S silencer, the second reporter gene and terminator, wherein, it can be inserted between promoter and the first reporter gene by cutting target dna sequence, first reporter gene is different from the second reporter gene, and the expression of REST gene is able to suppress the expression of the second reporter gene behind S silencer.The Genetic elements that frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene can be used as core element and be connected in carrier, it can be used to the cutting efficiency in living cells identification gRNA intracellular to genome, be the fluorescence phenotype and ease for operation of instant fluorescence phenotype, high stability when the detection is with generation frameshift mutation.
Description
Technical field
The present invention relates to the clone technologies and field of molecular detection in genetic engineering, in particular to a kind of use
Genetic elements and the application of frameshift mutation are generated in detection CRISPR/Cas9 gene editing system cutting gene.
Background technique
The short palindrome repetitive sequence in the interval of regular cluster (Clustered Regularly Interspaced Short
Palindromic Repeats, CRISPR) it is one of most of bacteriums and archeobacteria acquired immunity mode.2012,
Jinek etc. operates genomic DNA using CRISPR/Cas9 gene editing system, and confirms that this system can be
Active somatic cell realizes the gene editing that RNA is mediated.So far, CRISPR/Cas9 gene editing system is widely used in target gene
Editor.Especially in inductivity versatile stem cell (Induced Pluripotent Stem cells, iPS cells) or embryo
Application in tire stem cell (Embryonic Stem Cell, ESCs), uses CRISPR/Cas9 gene editing system modification base
Because the cell line for organizing obtained can imitate gene patient, the research and development for purpose new drug, specific drug;Or inactivation specific mutation
Gene achievees the purpose that gene editing treats disease.On the other hand, since CRISPR/Cas9 gene editing system is that RNA is mediated
, thus gRNA whether have single-minded cleavage site be it is most crucial, restrict CRISPR/Cas9 gene editing system and use
Factor is one of the key element for determining foregoing purpose realization.Therefore, gRNA design quality determines what target gene group was cut
Efficiency;The gRNA of specificity can reduce the probability that misses the target, and improve the accuracy of gene editing, avoid the editor of extra false.Institute
To need a kind of detection method to carry out gRNA designed by Rapid identification and generate frameshift mutation to the cutting efficiency of genome and editor
How genome base sequence afterwards is distributed.
Summary of the invention
The present invention is intended to provide a kind of generate frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene
Genetic elements and application, with provide it is a kind of quickly, can be in living cells identification gRNA intracellular to the cutting efficiency of genome
Method.
To achieve the goals above, according to an aspect of the invention, there is provided it is a kind of for detecting CRISPR/Cas9 base
Because editing system cutting gene generates the Genetic elements (CRISPR/Cas9Indel Assay system, CIAs) of frameshift mutation.
CIAs Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S silencer,
Two reporter genes and terminator, wherein it is can be inserted between promoter and the first reporter gene by cutting target dna sequence,
First reporter gene is different from the second reporter gene, and the expression of REST gene is able to suppress the second reporter gene behind silencer
Expression.
Further, Genetic elements further include the enhancer effectively connected.
Further, enhancer is cmv enhancer.
Further, the first reporter gene is red fluorescent protein gene, and the second reporter gene is green fluorescent protein base
Cause.
Further, promoter is EF1 promoter, and terminator is beta-globin polyadenylic acid.
Further, Genetic elements contain double enzyme site, and double enzyme site is located between promoter and the first report, quilt
Cutting target dna sequence is connected between double enzyme site.
Further, double enzyme site is Xba I and Kpn I restriction enzyme site.
Further, REST gene and the amplification of S silencer are in source of people H9 cell line.
Further, Genetic elements have the nucleotide sequence as shown in SEQ ID NO:1.
According to another aspect of the present invention, it provides a kind of for detecting CRISPR/Cas9 gene editing system cutting base
Because generating the carrier of frameshift mutation.The carrier includes any of the above-described kind of Genetic elements.
Further, carrier is pUC serial carrier, pEASY, pBlueScriptII or pBR322.
According to another aspect of the present invention, a kind of host cell is provided.The host cell includes any of the above-described kind and is used for
Detect the carrier that CRISPR/Cas9 gene editing system cutting gene generates frameshift mutation.
Further, host cell is Escherichia coli.
In accordance with a further aspect of the present invention, a kind of detection CRISPR/Cas9 gene editing system cutting gene production is provided
The method of raw frameshift mutation.This method is to cut base for detecting CRISPR/Cas9 gene editing system using any of the above-described kind
Carrier because generating frameshift mutation is detected.
Further, comprising the following steps: then S1 turns by any of the above-described kind of carrier insertion by cutting target dna sequence
Dye is transferred to the carrier (DNA sequence dna comprising expressing Cas9 albumen) for being mounted with gRNA into cell line;S2, observation first
The expression of reporter gene and the second reporter gene judges according to the expression of the first reporter gene and the second reporter gene
Whether gRNA produces frameshift mutation to the editor of target dna sequence.
Further, further includes: when the second reporter gene normal expression, be judged as CRISPR/Cas9 gene editing system
System cutting gene produces frameshift mutation, and expands target dna sequence and be sequenced.
Further, cell line is HEK293 cell line.
The Genetic elements of frameshift mutation are generated (referred to as detecting CRISPR/Cas9 gene editing system cutting gene
CIAs it) can be used as core element to be connected in carrier, can be used to imitate the cutting of genome in living cells identification gRNA intracellular
Rate, the detection have generate frameshift mutation when be instant fluorescence phenotype, high stability fluorescence phenotype and ease for operation, and
The vector construction has the remarkable advantage of the genetic manipulations such as simple, quick, time saving, laborsaving.
Detailed description of the invention
The accompanying drawings constituting a part of this application is used to provide further understanding of the present invention, and of the invention shows
Examples and descriptions thereof are used to explain the present invention for meaning property, does not constitute improper limitations of the present invention.In the accompanying drawings:
Fig. 1 shows Genetic elements CIAs composition schematic diagram.;
Fig. 2 a and 2b are respectively the plasmid map of the CIAs-pUC19 that Genetic elements CIAs of the invention is loaded and pCIAs.
Fig. 3 a and 3b points of target-pCIAs and target-1-pCIAs to load target DNA sequence.
Fig. 4 a, 4b, 4c and 4d are respectively the plasmid map for loading gRNA sequence.
Fig. 5 a, 5b, 5c and 5d are respectively that the light microscopic and fluorescence photo of bacterial strain to be edited are edited and do not had to target DNA.
Specific embodiment
It should be noted that in the absence of conflict, the features in the embodiments and the embodiments of the present application can phase
Mutually combination.The present invention will be described in detail below with reference to the accompanying drawings and embodiments.
For some technical problems existing in the prior art, the present invention provides a kind of detection CRISPR/Cas9 gene volume
The system of collecting cutting gene generates Genetic elements, carrier, host cell and the method for frameshift mutation.
A kind of typical embodiment according to the present invention provides a kind of for detecting CRISPR/Cas9 gene editing system
Cut the Genetic elements that gene generates frameshift mutation.The Genetic elements include the promoter effectively connected, the first reporter gene,
REST gene, SV40pA gene, S silencer, the second reporter gene and terminator, wherein promoter and the first reporter gene base
It is can be inserted into because between by cutting target dna sequence, the first reporter gene is different from the second reporter gene, the expression energy of REST gene
Enough inhibit the expression of the second reporter gene behind silencer.
" effectively connection " the i.e. conventional sense of field of biotechnology in the present invention, that is, the Genetic elements after connecting can rise
To its scheduled effect.
Target dna sequence is connected in said gene element, and gRNA/Cas9 complex cuts target dna sequence and generates
When frameshift mutation, the first reporter gene and REST gene can also generate frameshift mutation, be that cannot express correct first report base
Because of-REST fusion protein, the albumen of the first reporter gene can not be as generated, the second report behind S silencer can not be inhibited
The expression of gene.At this moment, the albumen of the second reporter gene can normal expression, can make host cell line generate second report
The signal of gene.
Target dna sequence is connected in Genetic elements CIAs, and gRNA/Cas9 complex cutting target dna sequence does not produce
When raw frameshift mutation, the first reporter gene and the correct first reporter gene-REST fusion protein of REST gene expression are as produced
The albumen of raw first reporter gene, while S silencer inhibits the expression of the second reporter gene below.At this moment, the first reporter gene
Can normal expression, and the second reporter gene is not expressed, so the signal of the first reporter gene.
When the first reporter gene is red fluorescent protein gene, and the second reporter gene is green fluorescence protein gene, mesh
Mark DNA sequence dna is connected in Genetic elements CIAs, when gRNA/Cas9 complex cuts target dna sequence generation frameshift mutation,
Genetic elements red fluorescent protein and REST gene can also generate frameshift mutation, be that cannot express correct red fluorescence-REST
Fusion protein as can not generate red fluorescent protein and not inhibit the expression of gene green fluorescent protein behind silencer.This
When, green fluorescent protein can normal expression, can make host generate green fluorescence.Target dna sequence is connected to gene
In element CIAs, when gRNA/Cas9 complex cutting target dna sequence does not generate frameshift mutation, Genetic elements red fluorescence egg
The white and correct red fluorescence-REST fusion protein of REST gene expression, as generation red fluorescent protein and inhibition silencer
The expression of gene green fluorescent protein below.At this moment, red fluorescent protein can normal expression, and green fluorescence is not table
It reaches, so host generates red fluorescence.
The sequence that said gene element CIAs is included by gene chemical synthesis or can be amplified from and contain this Genetic elements
Target nucleic acid sequence obtain, and linked together by the method for fusion DNA vaccine or homologous recombination.Composition sequence separate sources,
It can be applied to different cell lines.Wherein, a kind of typical embodiment, REST gene and S silencer expand according to the present invention
In source of people iPS or H9 cell line, it is more suitable for the gene frameshift mutation detection of human archeocyte system.
Preferably, Genetic elements further include the enhancer effectively connected, and preferred enhancer is cmv enhancer.
A kind of typical embodiment according to the present invention, promoter are EF1 promoter, and terminator is the poly- adenosine of beta-globin
Acid.
Convenient for target dna sequence, Genetic elements CIAs contains double enzyme site, and double enzyme site is located at promoter and first
Between report, it is connected between double enzyme site by cutting target dna sequence.Preferably, double enzyme site is Xba I and Kpn
I restriction enzyme site.
Preferably, Genetic elements CIAs has the nucleotide sequence as shown in SEQ ID NO:1.
SEQ ID NO:1
TGTAAAACGACGGCCAGTGAATTCGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGG
TCATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCA
ACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCA
ATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATT
GACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGT
ACATCTACGTATTAGTCATCGCTATTACCATGGAATAGCAACAGACATACAAACTAAAGAATTACAAAAACAAATT
ACAAAAATTCAAAATTTTATCGATACTAGTAAGGATCTGCGATCGCTCCGGTGCCCGTCAGTGGGCAGAGCGCACA
TCGCCCACAGTCCCCGAGAAGTTGGGGGGAGGGGTCGGCAATTGAACGGGTGCCTAGAGAAGGTGGCGCGGGGTAA
ACTGGGAAAGTGATGTCGTGTACTGGCTCCGCCTTTTTCCCGAGGGTGGGGGAGAACCGTATATAAGTGCAGTAGT
CGCCGTGAACGTTCTTTTTCGCAACGGGTTTGCCGCCAGAACACAGCTGAAGCTTCGAGGGGCTCGCATCTCTCCT
TCACGCGCCCGCCGCCCTACCTGAGGCCGCCATCCACGCCGGTTGAGTCGCGTTCTGCCGCCTCCCGCCTGTGGTG
CCTCCTGAACTGCGTCCGCCGTCTAGGTAAGTTTAAAGCTCAGGTCGAGACCGGGCCTTTGTCCGGCGCTCCCTTG
GAGCCTACCTAGACTCAGCCGGCTCTCCACGCTTTGCCTGACCCTGCTTGCTCAACTCTACGTCTTTGTTTCGTTT
TCTGTTCTGCGCCGTTACAGATCCAAGCTGTGACCGGCGCCTACATGTCTAGANNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNGGTACCGTGTCTAAGGGCGAAGAGCTGATTAAGGAGAACATGCACATGAAGCTGTACATGGAGGGCACC
GTGAACAACCACCACTTCAAGTGCACATCCGAGGGCGAAGGCAAGCCCTACGAGGGCACCCAGACCATGAGAATCA
AGGTGGTCGAGGGCGGCCCTCTCCCCTTCGCCTTCGACATCCTGGCTACCAGCTTCATGTACGGCAGCAAAACCTT
CATCAACCACACCCAGGGCATCCCCGACTTCTTTAAGCAGTCCTTCCCTGAGGGCTTCACATGGGAGAGAGTCACC
ACATACGAAGACGGGGGCGTGCTGACCGCTACCCAGGACACCAGCCTCCAGGACGGCTGCCTCATCTACAACGTCA
AGATCAGAGGGGTGAACTTCCCATCCAACGGCCCTGTGATGCAGAAGAAAACACTCGGCTGGGAGGCCTCCACCGA
GATGCTGTACCCCGCTGACGGCGGCCTGGAAGGCAGAAGCGACATGGCCCTGAAGCTCGTGGGCGGGGGCCACCTG
ATCTGCAACTTGAAGACCACATACAGATCCAAGAAACCCGCTAAGAACCTCAAGATGCCCGGCGTCTACTATGTGG
ACAGAAGACTGGAAAGAATCAAGGAGGCCGACAAAGAAACCTACGTCGAGCAGCACGAGGTGGCTGTGGCCAGATA
CTGCGACCTCCCTAGCAAACTGGGGCACAAACTTAATTAAGCCACCCAGGTAATGGGGCAGTCTTCTGGAGGAGGA
GGGCTGTTTACCAGCAGTGGCAACATTGGAATGGCCCTGCCTAACGACATGTATGACTTGCATGACCTTTCCAAAG
CTGAACTGGCCGCACCTCAGCTTATTATGCTGGCAAATGTGGCCTTAACTGGGGAAGTAAATGGCAGCTGCTGTGA
TTACCTGGTCGGTGAAGAAAGACAGATGGCAGAACTGATGCCGGTTGGGGATAACAACTTTTCAGATAGTGAAGAA
GGAGAAGGACTTGAAGAGTCTGCTGATATAAAAGGTGAACCTCATGGACTGGAAAACATGGAACTGAGAAGTTTGG
AACTCAGCGTCGTAGAACCTCAGCCTGTATTTGAGGCATCAGGTGCTCCAGATATTTACAGTTCAAATAAAGATCT
TCCCCCTGAAACACCTGGAGCGGAGGACAAAGGCAAGAGCTCGAAGACCAAACCCTTTCGCTGTAAGCCATGCCAA
TATGAAGCAGAATCTGAAGAACAGTTTGTGCATCACATCAGAGTTCACAGTGCTAAGAAATTTTTTGTGGAAGAGA
GTGCAGAGAAGCAGGCAAAAGCCAGGGAATCTGGCTCTTCCACTGCAGAAGAGGGAGATTTCTCCAAGGGCCCCAT
TCGCTGTGACCGCTGCGGCTACAATACTAATCGATATGATCACTATACAGCACACCTGAAACACCACACCAGAGCT
GGGGATAATGAGCGAGTCTACAAGTGTATCATTTGCACATACACAACAGTGAGCGAGTATCACTGGAGGAAACATT
TAAGAAACCATTTTCCAAGGAAAGTATACACATGTGGAAAATGCAACTATTTTTCAGACAGAAAAAACAATTATGT
TCAGCATGTTAGAACTCATACAGGAGAACGCCCATATAAATGTGAACTTTGTCCTTACTCAAGTTCTCAGAAGACT
CATCTAACTAGACATATGCGTACTCATTCAGGTGAGAAGCCATTTAAATGTGATCAGTGCAGTTATGTGGCCTCTA
ATCAACATGAAGTAACCCGCCATGCAAGACAGGTTCACAATGGGCCTAAACCTCTTAATTGCCCACACTGTGATTA
CAAAACAGCAGATAGAAGCAACTTCAAAAAACATGTAGAGCTACATGTGAACCCACGGCAGTTCAATTGCCCTGTA
TGTGACTATGCAGCTTCCAAGAAGTGTAATCTACAGTATCACTTCAAATCTAAGCATCCTACTTGTCCTAATAAAA
CAATGGATGTCTCAAAAGTGAAACTAAAGAAAACCAAAAAACGAGAGGCTGACTTGCCTGATAATATTACCAATGA
AAAAACAGAAATAGAACAAACAAAAATAAAAGGGGATGTGGCTGGAAAGAAAAATGAAAAGTCCGTCAAAGCAGAG
AAAAGAGATGTCTCAAAAGAGAAAAAGCCTTCTAATAATGTGTCAGTGATCCAGGTGACTACCAGAACTCGAAAAT
CAGTAACAGAGGTGAAAGAGATGGATGTGCATACAGGAAGCAATTCAGAAAAATTCAGTAAAACTAAGAAAAGCAA
AAGGAAGCTGGAAGTTGACAGCCATTCTTTACATGGTCCTGTGAATGATGAGGAATCTTCAACAAAAAAGAAAAAG
AAGGTAGAAAGCAAATCCAAAAATAATAGTCAGGAAGTGCCAAAGGGTGACAGCAAAGTGGAGGAGAATAAAAAGC
AAAATACTTGCATGAAAAAAAGTACAAAGAAGAAAACTCTGAAAAATAAATCAAGTAAGAAAAGCAGTAAGCCTCC
TCAGAAGGAACCTGTTGAGAAGGGATCTGCTCAGATGGACCCTCCTCAGATGGGGCCTGCTCCCACAGAGGCGGTT
CAGAAGGGGCCCGTTCAGGTGGAGCCGCCACCTCCCATGGAGCATGCTCAGATGGAGGGTGCCCAGATACGGCCTG
CTCCTGACGAGCCTGTTCAGATGGAGGTGGTTCAGGAGGGGCCTGCTCAGAAGGAGCTGCTGCCTCCCGTGGAGCC
TGCTCAGATGGTGGGTGCCCAAATTGTACTTGCTCACATGGAGCTGCCTCCTCCCATGGAGACTGCTCAGACGGAG
GTTGCCCAAATGGGGCCTGCTCCCATGGAACCTGCTCAGATGGAGGTTGCCCAGGTAGAATCTGCTCCCATGCAGG
TGGTCCAGAAGGAGCCTGTTCAGATGGAGCTGTCTCCTCCCATGGAGGTGGTCCAGAAGGAGCCTGTTCAGATAGA
GCTGTCTCCTCCCATGGAGGTGGTCCAGAAGGAACCTGTTAAGATAGAGCTGTCTCCTCCCATAGAGGTGGTCCAG
AAGGAGCCTGTTCAGATGGAGTTGTCTCCTCCCATGGGGGTGGTTCAGAAGGAGCCTGCTCAGAGGGAGCCACCTC
CTCCCAGAGAGCCTCCCCTTCACATGGAGCCAATTTCCAAAAAGCCTCCTCTCCGAAAAGATAAAAAGGAAAAGTC
TAACATGCAGAGTGAAAGGGCACGGAAGGAGCAAGTCCTTATTGAAGTTGGCTTAGTGCCTGTTAAAGATAGCTGG
CTTCTAAAGGAAAGTGTAAGCACAGAGGATCTCTCACCACCATCACCACCACTGCCAAAGGAAAATTTAAGAGAAG
AGGCATCAGGAGACCAAAAATTACTCAACACAGGTGAAGGAAATAAAGAAGCCCCTCTTCAGAAAGTAGGAGCAGA
AGAGGCAGATGAGAGCCTACCTGGTCTTGCTGCTAATATCAACGAATCTACCCATATTTCATCCTCTGGACAAAAC
TTGAATACGCCAGAGGGTGAAACTTTAAATGGTAAACATCAGACTGACAGTATAGTTTGTGAAATGAAAATGGACA
CTGATCAGAACACAAGAGAGAATCTCACTGGTATAAATTCAACAGTTGAAGAACCAGTTTCACCAATGCTTCCCCC
TTCAGCAGTAGAAGAACGTGAAGCAGTGTCCAAAACTGCACTGGCATCACCTCCTGCTACAATGGCAGCAAATGAG
TCTCAGGAAATTGATGAAGATGAAGGCATCCACAGCCATGAAGGAAGTGACCTAAGTGACAACATGTCAGAGGGTA
GTGATGATTCTGGATTGCATGGGGCTCGGCCAGTTCCACAAGAATCTAGCAGAAAAAATGCAAAGGAAGCCTTGGC
AGTCAAAGCGGCTAAGGGAGATTTTGTTTGTATCTTCTGTGATCGTTCTTTCAGAAAGGGAAAAGATTACAGCAAA
CACCTCAATCGCCATTTGGTTAATGTGTACTATCTTGAAGAAGCAGCTCAAGGGCAGGAGTAAAGCTGAATCTAAG
TCGACTTAAGAACCGCTCGAGGCCGGCAAGGCCGGATCCAGACATGATAAGATACATTGATGAGTTTGGACAAACC
ACAACTAGAATGCAGTGAAAAAAATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAA
GCTGCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGGAGGTGTGGGAGGTTTT
TTAAAGCAAGTAAAACCTCTACAAATGTGGTATGGCTGATTATGATCTCATTCATCCTTTTCTCCTCGTCCCTCCT
TCATTCATTCATAGCCCCCCGCCCTGCCCGCTTCAGCATTTCATTCATTCATTCATTCATTCATTTCCCGGAGCTC
CGCTAGCGCACACCCCTTCAGCCGAAGGCCCCAGCGCGCAGGCGCAGGCCGGGAGAGGCAGGCACCCTCCAATCGT
CGGGCGTCCTTCCTCCTCCGGGCGGCCGCCCGCTTCCCCATGAATGAACATTGACGTCAATGGGGCGGGGCGCGCC
CACGTGACCCCGCGCGCTCCCCTTTATAAGGCGGTGGAGGCGCGGGCGCTGTCCAGCGTGCTGAAGCCGGAGCGAG
CTAGCCGCCCGGAGCCGCGCCGACCCAGCTGAGCCCAGCCCACGGGACGCCAGACCTCGACCGTCGCTCCTACCCC
GGCCACCGCTCGGAGCCGAGGCGGACGCGTCCCGATCTTCCCCTGTCCCCACCCTGCCCCGACCCTCCTCTCCACC
TCTCGCGTCGTGACACCAGCTGGTAAATACTCCGCTGTTCGTCCCTCAAACCCTCGGCAGCCAGCCGTGGGCGTGA
GGGAGGGTTCTCTCTCCTCTCGATGGGGGTGTTGCAAACACAGCGGGGAGCCCCCTGGTAAGGGTCCCCGGTAAAC
GGGGGAGTCGCAGCTTTTTCTCTTGCTGCTGAAGTCGCCCACGCACCATCCGGGGAGTCCTACGGGGAGGGAGCAG
AGATTTTTTTTTCCCCCATATTGCTGCTGCTTAGTACGTGGGCGATGGCAGTGAGATGGCTCAGGGAAGGGGCCGA
GGAGGCCCTGGGTAAGCGAGGGCTTCGGGGGTTATTTTCCCATTTACACGGCTCCAGAGATCGGCACAACATCTTC
CTCCTTTGCTCCTAAACGTTCCTCTTCTGGGTAAGGTTTGGGGGATCAGGGAAGCCCCGGGTTTCCTGCTGAAAGG
TGGGGGAAGGGAACGTAGACCTAGAGAGGGGAATTCTTACAGAAATCCTCTTTTTTTGGTCCCTTCTATTTTTCAG
TCTCCGGCAGCCTCTTGGTCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCT
GGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACC
CTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGC
AGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCA
GGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG
GTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACT
ACAACAGCCACAACGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAA
CATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTG
CCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGC
TGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAAACGCGTGAATTCACTCCTCA
GGTGCAGGCTGCCTATCAGAAGGTGGTGGCTGGTGTGGCCAATGCCCTGGCTCACAAATACCACTGAGATCTTTTT
CCCTCTGCCAAAAATTATGGGGACATCATGAAGCCCCTTGAGCATCTGACTTCTGGCTAATAAAGGAAATTTATTT
TCATTGCAATAGTGTGTTGGAATTTTTTGTGTCTCTCACTCGGAAGGACATATGGGAGGGCAAATCATTTAAAACA
TCAGAATGAGTATTTGGTTTAGAGTTTGGCAACATATGCCCATATGCTGGCTGCCATGAACAAAGGTTGGCTATAA
AGAGGTCATCAGTATATGAAACAGCCCCCTGCTGTCCATTCCTTATTCCATAGAAAAGCCTTGACTTGAGGTTAGA
TTTTTTTTATATTTTGTTTTGTGTTATTTTTTTCTTTAACATCCCTAAAATTTTCCTTACATGTTTTACTAGCCAG
ATTTTTCCTCCTCTCCTGACTACTCCCAGTCATAGCTGTCCCTCTTCTCTTATGGAGATCCCTCGACCTGCAGCCC
AAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTG。
A kind of typical embodiment according to the present invention provides a kind of for detecting CRISPR/Cas9 gene editing system
Cut the carrier that gene generates frameshift mutation.The carrier includes any of the above-described kind of Genetic elements.Genetic elements CIAs can connect
Realize that stablizing for CIAs nucleic acid sequence is lost into pUC series or other cloned plasmids or other function property grain or host genome
It passes, can be transferred in different hosts and be functioned with different carrier format passenger gene element CIAs.
A kind of typical embodiment according to the present invention, provides a kind of host cell.The host cell includes any of the above-described
Kind generates the carrier of frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene, such as host cell is big
Enterobacteria.The carrier for being used to detect the cutting gene generation frameshift mutation of CRISPR/Cas9 gene editing system is transformed into large intestine
In bacillus, plasmid is extracted from positive colony.Genetic elements CIAs can carry out the codon optimization of different plant species, can be not
It functions with host cell.
A kind of typical embodiment according to the present invention provides a kind of detection CRISPR/Cas9 gene editing system cutting
The method of gene generation frameshift mutation.This method includes using above-mentioned for detecting the cutting of CRISPR/Cas9 gene editing system
The carrier that gene generates frameshift mutation is detected.
Preferably, comprising the following steps: above-mentioned carrier is inserted by cutting target dna sequence, then transfects to cell by S1
In system, while being transferred to the carrier for being mounted with gRNA;S2 observes the expression of the first reporter gene and the second reporter gene, root
Judge whether gRNA produces shifting to the editor of target dna sequence according to the expression of the first reporter gene and the second reporter gene
Code mutation.Preferably, when the second reporter gene normal expression, it is judged as that CRISPR/Cas9 gene editing system cuts gene
Frameshift mutation is produced, and expands target dna sequence and is sequenced.Wherein, it is preferred that cell line is HEK293 cell line.
HEK293 cell line is easy transfectional cell series, convenient for quickly detection.
Constructing Genetic elements CIAs of the invention facilitates gRNA/Cas9 complex cutting target DNA sequence in identification of cell
The frameshift mutation situation generated after column and other possible pairing DNA sequence dnas, further to provide volume intracellular to the gRNA of design
Volume information and provide background information for gene editing application.The pCIAs plasmid that the present invention constructs (includes said gene element
Carrier, such as: SEQ ID NO:1) can be directly connected to target DNA sequence, transfect into HEK293 cell line, be transferred to simultaneously
The carrier of the loading gRNA of design.After 48 hours, determined in fluorescin that fluorescence microscopy microscopic observation cell is expressed
Whether gRNA produces frameshift mutation to the editor of target DNA sequence.After extracting DNA for the green fluorescence strain showed,
PCR amplification target DNA sequence measures nucleic acid sequence after loading using carrier T, for identifying DNA sequence dna to be edited.
A kind of typical embodiment according to the present invention, Genetic elements CIAs is as shown in Figure 1, synthesized by DNA sequence dna
Mode obtain.The CIAs sequence of synthesis needs to load CIAs to pUC19 plasmid by Sanger sequence verification.
A kind of typical embodiment according to the present invention, the application method of functional vector, comprising the following steps: A. is used
PCR amplification linearizes CIAs;B. target fragment CIAs is connected in the pPuro plasmid of linearisation and obtains purpose plasmid
CIAs-pPuro (or being pCIAs);C. the step B plasmid obtained is converted into Escherichia coli, screens correct clone,
And pass through Sanger sequence verification;D. after cutting pCIAs plasmid using Xba I and Kpn I digestion, connection target DNA sequence is extremely
PCIAs plasmid.In one embodiment, it is transferred to different target DNA sequences respectively to pCIAs plasmid, and is transferred to gRNA carrier, comes
It verifies cleavage activity and causes the base sequence after frameshift mutation.
The pCIAs plasmid can be used as the starting vector of testing goal DNA sequence dna, and the carrier have it is simple, quickly,
The remarkable advantage of the genetic manipulations such as time saving, laborsaving, can be used for detecting gRNA to target DNA cleavage activity verifying and it is edited
DNA sequence analysis confirmation.
The carrier that the present invention does the detection CRISPR/Cas9 gene editing system cutting gene generation frameshift mutation constructed can
After whether being frameshift mutation and generate frameshift mutation with the mutation after the cutting of genome caused by the gRNA of quick detection design
Generated base knocks out type and type probability.Method of the present invention can be quick, efficient, instant and stable detection
The gRNA/Cas9 complex of design cuts postgenome, and whether the genotype repaired, which meets experiment, is expected, and grinds in gene function
Studying carefully aspect has great significance.
In an exemplary embodiment of the invention, the technical advantage of the mechanism of action of Genetic elements CIAs is, by mesh
DNA sequence dna load to pCIAs (pCIAs is the title that CIAs is connected on carrier) plasmid after, while turning gRNA carrier extremely
In HEK293 cell line, it can quickly detect whether gRNA can cut target DNA sequence in time.Since pCIAs can be carried
There is Puro resistance screening gene, so can remove the cell for not being transferred to purpose plasmid after addition puro, reduce high background
Disadvantage.
In order to verify the cleavage activity and edited base sequence that Genetic elements CIAs quickly detects gRNA, the present invention
In one embodiment, it loads in target DNA sequence to pCIAs, while turning gRNA vector plasmid and going to HEK293 cell together
In system.After puro will be screened, the expression of fluorescence microscope reporter gene is used.If cell expression green is glimmering
Light indicates that gRNA can cut target DNA sequence;If cell expresses red fluorescence, indicate that gRNA is cannot to cut mesh
DNA sequence dna.In addition, target dna sequence base situation to be edited is identified by the DNA for extracting cell line, to analyze
Edited result and determine suitable gRNA.
Beneficial effects of the present invention are further illustrated below in conjunction with embodiment.In the present invention for detailed description the step of or
Reagent can be realized or be used the conventional reagent of this field using ordinary skill in the art means.
Embodiment 1
In the following embodiments, enzyme used is purchased from NEB, and HEK293 cell line matches the limited public affairs of shellfish biotechnology from Beijing
Department.Genetic elements cmv enhancer, EF1 promoter, red fluorescent protein gene, REST gene, SV40pA terminator, S silencing
The sequence information of son, green fluorescence protein gene and beta-globin polyadenylic acid comes from ncbi database, and synthesis is public by gold only intelligence
Department completes, and (see Fig. 2 a) in reprinting to pUC19 plasmid.It is that Genetic elements CIAs illustrates map with reference to Fig. 1.
The present invention obtains pCIAs plasmid (Fig. 2 b) by genetic manipulation process, and example process is as follows:
The DNA of the plasmid pPuro of 300ng is mixed with 0.5 μ l restriction enzyme Xha I, carries out digestion, 37 DEG C of water-baths
1h obtains linearized vector segment pPuro after recycling.Using CIAs-pUC19 plasmid as template, with CIA-P1 (SEQ ID NO:2)
It is primer amplification CIAs sequence with CIA-P2 (SEQ ID NO:3).Above-mentioned 2 segment is connected using SLIC cloning process.By 100ng
PPuro and Insert Fragment CIAs according to molar ratio 1:2, handled at room temperature 2.5 minutes using the T4DNA polymerase of 0.5U,
Subsequent ice bath is simultaneously converted into Escherichia coli, is coated on containing correct clone is screened on Amp plate, is obtained plasmid pCIAs,
And carry out sequence verification.
SEQ ID NO:2
GTAAAACGACGGCCAGTGAATTCGACATTGATTATTGACTAGTTATTAATAG
SEQ ID NO:3
GCCAAGCTTGGGCTGCAGGTCGAGGGATCTCCATAAGAGAAG
Embodiment 2
Using H9 cell line genome DNA as template, primer target-p-1 (SEQ ID NO:4) and target- is used
P-2 (SEQ ID N NO:5) carries out PCR reaction.Response procedures: 98 DEG C initial denaturation 5 minutes;98 DEG C of deformation 10s, 60 DEG C of annealing
15s, 72 DEG C of extension 1min, 35 circulations;72 DEG C of extension 10min.After recycling, target DNA sequence (as target sequence is obtained
Column, SEQ ID NO:6).
By the DNA of the plasmid pCIAs of 300ng and restriction enzyme Xba I and Kpn I digestion (respectively 0.5 μ l and
0.5 μ l) mixing, digestion is carried out, 37 DEG C of water-bath 1h obtain linearized vector segment pCIAs after recycling.Use SLIC cloning process
Connect above-mentioned 2 segment.By the pCIAs of 100ng and Insert Fragment target sequence according to molar ratio 1:2, the T4DNA of 0.5U is utilized
Polymerase is handled 2.5 minutes at room temperature, and subsequent ice bath is simultaneously converted into Escherichia coli, is coated on containing screening on Amp plate
Correct clone obtains plasmid target-pCIAs (Fig. 3 a), and carries out sequence verification.
In order to verify whether to be due to caused by DNA sequence dna as a result, being employed herein intragenic one section of HLA-E
DNA sequence dna is as DNA sequence dna comparative experiments.According to the process described above, using primer target-1-p-1 (SEQ ID NO:
7) target-1 sequence (SEQ ID N NO:9) is obtained, load is connected to target-1-p-2 (SEQ ID N NO:8), amplification
Plasmid target-1-pCIAs (Fig. 3 b) is obtained on body, and carries out sequence verification.
SEQ ID NO:4
GTCTAGACTCCCTGATCGCCTATAGATC
SEQ ID NO:5
CGGTACCCATGAAGAAAGCAGGTGTGGG
SEQ ID NO:6
CATGAAGAAAGCAGGTGTGGGTCCTGGACCAATAGCCCTCCTGAGGTCTGTCCTCAGGGACCTTCCCCT
GTGACTTGTGACTGCTGGGATCAGGTCCCATCACCGCCGTAATCAAGGTGATAAATCTGTCCTTCATTTTAACAGGT
GCTTTACAAAAGAGTAAGTGCTGGCACACAGGGCCCAGGCTGGGTCGGCCCATGATTGTGGAAGGTGCTTCCCAGTA
ATGAGACAGGGCACATTTCTAGCTGGGGCTTGGAACCCTCAGTGAGACAAGAAATCTCAGACCCCACCCTTCACCCC
TTCTCCACCTGAGCTCTTCCTCCTCCACATCACGGCAGCGACCACAGCTCCAGTGATCACAGCTCCAAGGAGAACCA
GGCCAGCAATGATGCCCACGATGGGGATGGTGGGCTGGGAAGACAGCTCTGGGAAAAGAGGGGAAGGTGAGGGGCCC
TGACCCTGCTAAAGGTCTCCAGAGAGGCTCCTGCTTTCCCTAAGAGACATGACACCCCCATCTCCCTCCTTACCCCA
TCTCAGGGTGAGGGGCTTGGGCAGACCCTCATGCTGCACATGGCAGGTGTATCTCTGCTCCTCTCCAGAAGGCACCA
CCACAGCCGCCCACTTCTGGAAGGTTCCATCCCCTGCAGGCCTGGTCTCCACGAGCTCCGTGTCCTGGGTCTGGTCC
TCCCCATCCCGCTGCCAGGTCAGTGTGATCTCCGCAGGGTAGAAGCCCAGGGCCCAGCACCTCAGGGTGGCCTCATG
GTCAGAGATGGGGTGGTGGGTCATATGTGTCTTGGGGGGGTCTGACGGGAAGAGTCAGAAAATTCAGGCATTTTGCA
TCTGTCATGGGACACTCCACCAGCACGCATGTGGCCATCTTGAGAATGGACAGGACACCCGGGATGGGGAAGAGAGC
ACAGAACCCAGACACCAGCCTGGACACAGGCACCTGGGATAATCTTCTATTCCCTGAGAAGGGAACAGCGACTTCTG
GTCCTGACCTGAGTGGAGGCTGAGAGACTCAGAAGTGCTGGACTCAGACCCCCACACACATTGAGTGTGAAGCAGAG
AACAAGGCCTGAGAGGAAAAGTCACGGGCCCAAGGCTGCTGCCGGTGTCAAAGGGAACCACTCATCAGTATTCGAGG
GATCGTCTTCCCGTCACTCCTTCAGAGATTTTATCCCTTAATTGTGTCAGAGAGCAGGGCGGAACCTCAGAGTCACT
CTCTGGTACAGGATCTGGAAACCCAGGAGGATTCCTCTCCCTCAGGACCAGAGGGAGGGTGATATTCTAGTGTTGGT
CCCAATTGTCTCCCCTCCTTGTGGGAGGCCAGCCCGGGAGATCTATAGGCGATCAGGGAG
SEQ ID NO:7
CGGTACCGCAGACTCAGTTCTCATTCC
SEQ ID NO:8
GTCTAGAGCCTGTGTGGATGCTGAGTG
SEQ ID NO:9
GCAGACTCAGTTCTCATTCCCAATGGGTGTCGGGTTTCTAGAGAAGCCAATCAGCGTCGCCACGACTCC
CGACTATAAAGTCCCCATCCGGACTCAAGAAGTTCTCAGGACTCAGAGGCTGGGATCATGGTAGATGGAACCCTCCT
TTTACTCCTCTCGGAGGCCCTGGCCCTTACCCAGACCTGGGCGGGTGAGTGCGGGGTCGGGATGGAAACGGCCTCTA
CCGGGAGTAGAGAGGGGCCGGCCCGGCGGGGGCGAAGGACTCGGGGAGCCGCGCCGGGAGGAGGGTCGGGCCGATCT
CAGCCCCTCCTCGCCCCCAGGCTCCCACTCCTTGAAGTATTTCCACACTTCCGTGTCCCGGCCCGGCCGCGGGGAGC
CCCGCTTCATCTCTGTGGGCTACGTGGACGACACCCAGTTCGTGCGCTTCGACAACGACGCCGCGAGTCCGAGGATG
GTGCCGCGGGCGCCGTGGATGGAGCAGGAGGGGTCAGAGTATTGGGACCGGGAGACACGGAGCGCCAGGGACACCGC
ACAGATTTTCCGAGTGAATCTGCGGACGCTGCGCGGCTACTACAATCAGAGCGAGGCCGGTGAGTGACCCCGGCCAG
GGGAGCAGGTCACGACCCCTCCCCATCCCCCACGGACGGCGCGGGTCCCCTCGAATCTTCGGGTCCCAGATTCACCC
CAAGGCTGCGGAACCCGCCCAGACCCTAGACCGGGGAGAGTCTCAGGCGCCTTTACCCGGTTCTTTTTCAGTTTAGG
CCAAAATGCCCACAGGGTGGTGGCGACGGGGGCGGGGCTTGGTGGGCGGGACTGACTAAGGGGCGGGGCCAGGGTCT
CACACCCTGCAGTGGATGCATGGCTGCGAGCTGGGGCCCGACGGGCGCTTCCTCCGCGGGTATGAACAGTTCGCCTA
CGACGGCAAGGATTATCTCACCCTGAATGAGGACCTGCGCTCCTGGACCGCGGTGGACACGGCGGCTCAGATCTCCG
AGCAAAAGTCAAATGATGCCTCTGAGGCGGAGCACCAGAGAGCCTACCTGGAAGACACATGCGTGGAGTGGCTCCAC
AAATACCTGGAGAAGGGGAAGGAGACGCTGCTTCACCTGGGTAAGAGGGTCCACAGGGCTACTCTCCCATCTCCTTC
TTGGGCTAGGACTGTGCCCACAGCTGACAGACCTCAAACAGTAGAAGAAACAGGGATGGAGGCCAGAATACCACTCC
TCCCTTGGATCAGGAGAGGGAGCTGTCACCTGAGGTACAGGAGATCCTATACCACAGAGTGACTCTCTTAAAGGGCC
AGACCTCTCTCAGGGGCAATTAAGGAATCTAGTCTCGCTGGAGATTCCATCCTTCAGATGAACTGATGAGCAGTTCT
CTTTGACTCCCAGTATTAGGAATCACGGGGGAGTTTCTCTCGTGCCTGATTCTCAGCCCCACACCAAGAGTTTTTGG
AGGTCTGACTCCAGCTTTTCTCAGTCACTCAGCATCCACACAGGC
Embodiment 3
For the cleavage activity of the gRNA of test-target gene.First choice needs to load target gRNA to carrier, required
The operation wanted is as follows:
After carrying out gRNA design for target HLA-A gene in the present invention, primer gRNA12b-p-01 (SEQ ID is used
NO:10 cycle of annealing) and after gRNA12b-p-02 (SEQ ID NO:11) mixing is executed in PCR instrument, obtains gRNA12b piece
Section.
The DNA of the plasmid pHS-Cas 9 of 300ng is mixed with restriction enzyme Kpn I digestion (for 0.5 μ l), is carried out
Digestion, 37 DEG C of water-bath 1h obtain linearized vector pHS-Cas 9 after recycling.
Above-mentioned product is connected using T4 ligase, and is converted into Escherichia coli, is coated on containing being screened on Amp plate
Correct clone obtains plasmid gRNA12b-pHS-Cas 9 (Fig. 4 a), and carries out sequence verification.
When if necessary to detect more gRNA, then the carriers for being transferred to multiple loading gRNA is needed to can be realized.
In addition, be designed gRNAa to target gene HLA-A, the primer used be gRNAa-p-01 (SEQ ID NO:
12) and gRNAa-p-02 (SEQ ID NO:13), the site cut are to detect and work as purpose sequence not in target sequence
It is that red fluorescent protein can be guided to express when arranging the not cleavage site of Cas9/gRNAa, used construction method is above-mentioned
Construction method, the present invention construct plasmid gRNAa-pHS-Cas 9 (Fig. 4 b)
Meanwhile according to above design principle, to another section of DNA sequence (SEQ ID NO:9) gene editing in the present invention
It is analyzed.Designed gRNA is respectively sg01RNA-pHS-Cas9 (Fig. 4 c) and sg04RNA-pHS-Cas9 (Fig. 4 d).
SEQ ID NO:10
GTGGAAAGGACGAAACACCGCGTGGAGACCAGGCCTGCAG
SEQ ID NO:11
GCTATTTCTAGCTCTAAAACCTGCAGGCCTGGTCTCCACG
SEQ ID NO:12
GTGGAAAGGACGAAACACCGTTACAAGTAAGACCTACTCC
SEQ ID NO:13
GCTATTTCTAGCTCTAAAACGGAGTAGGTCTTACTTGTAA
Embodiment 4
According to the experimental program of Lipofectamine 3000, by plasmid target-pCIAs, gRNA12b-pHS-Cas
9, target-1-pCIAs and sg01RNA-pHS-Cas9 is transferred in HEK293 cell line simultaneously respectively.37 degree of incubated cell 2-4
After it, in fluorescence microscopy microscopic observation cell, it is found that green fluorescence (Fig. 5 a and Fig. 5 c) is presented in cell, illustrate target dna sequence
It is to produce frameshift mutation.
The DNA for extracting this cell line, using primer JD-p-1 (SEQ ID NO:14) and JD-p-2 (SEQ ID NO:
15) amplified fragments.Above-mentioned segment is connected using carrier T, converts into Escherichia coli, is coated on containing on Amp plate.By 20
After the random picking of clone spreads cultivation, sequencing company is sent to carry out sequencing verifying.
SEQ ID NO:14
GGTGCCCTCCATGTACAGC
SEQ ID NO:15
CTGCGCCGTTACAGATCCAA
Embodiment 5
According to embodiment 3 and method as described in example 4, plasmid gRNAa-pHS-Cas 9 (Fig. 4 b) and gRNAb- are constructed
It pHS-Cas 9 (Fig. 4 d) and goes in HEK293 cell line with target-pCIAs, target-1-pCIAs simultaneously respectively.37
Degree is after incubated cell 2-4 days, in fluorescence microscopy microscopic observation cell, it is found that red fluorescence (Fig. 5 b and Fig. 5 d) is presented in cell, says
Bright gRNA sequence does not cut target dna sequence.
The DNA for extracting this cell line, using primer JD-p-1 (SEQ ID No:14) and JD-p-2 (SEQ ID No:
15) amplified fragments.Above-mentioned segment is connected using carrier T, converts into Escherichia coli, is coated on containing on Amp plate.By 20
After the random picking of clone spreads cultivation, sequencing company is sent to carry out sequencing verifying.
It can be seen from the above description that the above embodiments of the present invention realized the following chievements:
1) compared to genome editor's situation in direct testing goal host, plasmid pCIAs constructed by the present invention, when
Target DNA sequence is gone to after loading to pCIAs in HEK293 cell line, and the cleavage activity and analysis that can quickly detect gRNA are cut
Base sequence after cutting;
2) being using advantage possessed by plasmid constructed by the present invention and detection method being capable of quick, easy detection purpose
DNA sequence dna edits situation by different gRNA, can greatly save test period and operation link, reduces experimental cost, makes section
Arriving for efficiency is ground to improve;
3) for more gRNA testing requirements, the method for the present invention is also that can provide detection gRNA cleavage activity and edited
Genome editor's situation, and analysis OFF-target sequence can be carried out with the presence or absence of situation to be edited.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field
For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair
Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.
Sequence table
<110>Beijing Sai Bei Bioisystech Co., Ltd
<120>Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene
<130> PN90870SBSW
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 7703
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(7703)
<223>Genetic elements CIAs
<400> 1
tgtaaaacga cggccagtga attcgacatt gattattgac tagttattaa tagtaatcaa 60
ttacggggtc attagttcat agcccatata tggagttccg cgttacataa cttacggtaa 120
atggcccgcc tggctgaccg cccaacgacc cccgcccatt gacgtcaata atgacgtatg 180
ttcccatagt aacgccaata gggactttcc attgacgtca atgggtggag tatttacggt 240
aaactgccca cttggcagta catcaagtgt atcatatgcc aagtacgccc cctattgacg 300
tcaatgacgg taaatggccc gcctggcatt atgcccagta catgacctta tgggactttc 360
ctacttggca gtacatctac gtattagtca tcgctattac catggaatag caacagacat 420
acaaactaaa gaattacaaa aacaaattac aaaaattcaa aattttatcg atactagtaa 480
ggatctgcga tcgctccggt gcccgtcagt gggcagagcg cacatcgccc acagtccccg 540
agaagttggg gggaggggtc ggcaattgaa cgggtgccta gagaaggtgg cgcggggtaa 600
actgggaaag tgatgtcgtg tactggctcc gcctttttcc cgagggtggg ggagaaccgt 660
atataagtgc agtagtcgcc gtgaacgttc tttttcgcaa cgggtttgcc gccagaacac 720
agctgaagct tcgaggggct cgcatctctc cttcacgcgc ccgccgccct acctgaggcc 780
gccatccacg ccggttgagt cgcgttctgc cgcctcccgc ctgtggtgcc tcctgaactg 840
cgtccgccgt ctaggtaagt ttaaagctca ggtcgagacc gggcctttgt ccggcgctcc 900
cttggagcct acctagactc agccggctct ccacgctttg cctgaccctg cttgctcaac 960
tctacgtctt tgtttcgttt tctgttctgc gccgttacag atccaagctg tgaccggcgc 1020
ctacatgtct agannnnnnn nnnnnnnnnn nnnnnnnnnn nnnggtaccg tgtctaaggg 1080
cgaagagctg attaaggaga acatgcacat gaagctgtac atggagggca ccgtgaacaa 1140
ccaccacttc aagtgcacat ccgagggcga aggcaagccc tacgagggca cccagaccat 1200
gagaatcaag gtggtcgagg gcggccctct ccccttcgcc ttcgacatcc tggctaccag 1260
cttcatgtac ggcagcaaaa ccttcatcaa ccacacccag ggcatccccg acttctttaa 1320
gcagtccttc cctgagggct tcacatggga gagagtcacc acatacgaag acgggggcgt 1380
gctgaccgct acccaggaca ccagcctcca ggacggctgc ctcatctaca acgtcaagat 1440
cagaggggtg aacttcccat ccaacggccc tgtgatgcag aagaaaacac tcggctggga 1500
ggcctccacc gagatgctgt accccgctga cggcggcctg gaaggcagaa gcgacatggc 1560
cctgaagctc gtgggcgggg gccacctgat ctgcaacttg aagaccacat acagatccaa 1620
gaaacccgct aagaacctca agatgcccgg cgtctactat gtggacagaa gactggaaag 1680
aatcaaggag gccgacaaag aaacctacgt cgagcagcac gaggtggctg tggccagata 1740
ctgcgacctc cctagcaaac tggggcacaa acttaattaa gccacccagg taatggggca 1800
gtcttctgga ggaggagggc tgtttaccag cagtggcaac attggaatgg ccctgcctaa 1860
cgacatgtat gacttgcatg acctttccaa agctgaactg gccgcacctc agcttattat 1920
gctggcaaat gtggccttaa ctggggaagt aaatggcagc tgctgtgatt acctggtcgg 1980
tgaagaaaga cagatggcag aactgatgcc ggttggggat aacaactttt cagatagtga 2040
agaaggagaa ggacttgaag agtctgctga tataaaaggt gaacctcatg gactggaaaa 2100
catggaactg agaagtttgg aactcagcgt cgtagaacct cagcctgtat ttgaggcatc 2160
aggtgctcca gatatttaca gttcaaataa agatcttccc cctgaaacac ctggagcgga 2220
ggacaaaggc aagagctcga agaccaaacc ctttcgctgt aagccatgcc aatatgaagc 2280
agaatctgaa gaacagtttg tgcatcacat cagagttcac agtgctaaga aattttttgt 2340
ggaagagagt gcagagaagc aggcaaaagc cagggaatct ggctcttcca ctgcagaaga 2400
gggagatttc tccaagggcc ccattcgctg tgaccgctgc ggctacaata ctaatcgata 2460
tgatcactat acagcacacc tgaaacacca caccagagct ggggataatg agcgagtcta 2520
caagtgtatc atttgcacat acacaacagt gagcgagtat cactggagga aacatttaag 2580
aaaccatttt ccaaggaaag tatacacatg tggaaaatgc aactattttt cagacagaaa 2640
aaacaattat gttcagcatg ttagaactca tacaggagaa cgcccatata aatgtgaact 2700
ttgtccttac tcaagttctc agaagactca tctaactaga catatgcgta ctcattcagg 2760
tgagaagcca tttaaatgtg atcagtgcag ttatgtggcc tctaatcaac atgaagtaac 2820
ccgccatgca agacaggttc acaatgggcc taaacctctt aattgcccac actgtgatta 2880
caaaacagca gatagaagca acttcaaaaa acatgtagag ctacatgtga acccacggca 2940
gttcaattgc cctgtatgtg actatgcagc ttccaagaag tgtaatctac agtatcactt 3000
caaatctaag catcctactt gtcctaataa aacaatggat gtctcaaaag tgaaactaaa 3060
gaaaaccaaa aaacgagagg ctgacttgcc tgataatatt accaatgaaa aaacagaaat 3120
agaacaaaca aaaataaaag gggatgtggc tggaaagaaa aatgaaaagt ccgtcaaagc 3180
agagaaaaga gatgtctcaa aagagaaaaa gccttctaat aatgtgtcag tgatccaggt 3240
gactaccaga actcgaaaat cagtaacaga ggtgaaagag atggatgtgc atacaggaag 3300
caattcagaa aaattcagta aaactaagaa aagcaaaagg aagctggaag ttgacagcca 3360
ttctttacat ggtcctgtga atgatgagga atcttcaaca aaaaagaaaa agaaggtaga 3420
aagcaaatcc aaaaataata gtcaggaagt gccaaagggt gacagcaaag tggaggagaa 3480
taaaaagcaa aatacttgca tgaaaaaaag tacaaagaag aaaactctga aaaataaatc 3540
aagtaagaaa agcagtaagc ctcctcagaa ggaacctgtt gagaagggat ctgctcagat 3600
ggaccctcct cagatggggc ctgctcccac agaggcggtt cagaaggggc ccgttcaggt 3660
ggagccgcca cctcccatgg agcatgctca gatggagggt gcccagatac ggcctgctcc 3720
tgacgagcct gttcagatgg aggtggttca ggaggggcct gctcagaagg agctgctgcc 3780
tcccgtggag cctgctcaga tggtgggtgc ccaaattgta cttgctcaca tggagctgcc 3840
tcctcccatg gagactgctc agacggaggt tgcccaaatg gggcctgctc ccatggaacc 3900
tgctcagatg gaggttgccc aggtagaatc tgctcccatg caggtggtcc agaaggagcc 3960
tgttcagatg gagctgtctc ctcccatgga ggtggtccag aaggagcctg ttcagataga 4020
gctgtctcct cccatggagg tggtccagaa ggaacctgtt aagatagagc tgtctcctcc 4080
catagaggtg gtccagaagg agcctgttca gatggagttg tctcctccca tgggggtggt 4140
tcagaaggag cctgctcaga gggagccacc tcctcccaga gagcctcccc ttcacatgga 4200
gccaatttcc aaaaagcctc ctctccgaaa agataaaaag gaaaagtcta acatgcagag 4260
tgaaagggca cggaaggagc aagtccttat tgaagttggc ttagtgcctg ttaaagatag 4320
ctggcttcta aaggaaagtg taagcacaga ggatctctca ccaccatcac caccactgcc 4380
aaaggaaaat ttaagagaag aggcatcagg agaccaaaaa ttactcaaca caggtgaagg 4440
aaataaagaa gcccctcttc agaaagtagg agcagaagag gcagatgaga gcctacctgg 4500
tcttgctgct aatatcaacg aatctaccca tatttcatcc tctggacaaa acttgaatac 4560
gccagagggt gaaactttaa atggtaaaca tcagactgac agtatagttt gtgaaatgaa 4620
aatggacact gatcagaaca caagagagaa tctcactggt ataaattcaa cagttgaaga 4680
accagtttca ccaatgcttc ccccttcagc agtagaagaa cgtgaagcag tgtccaaaac 4740
tgcactggca tcacctcctg ctacaatggc agcaaatgag tctcaggaaa ttgatgaaga 4800
tgaaggcatc cacagccatg aaggaagtga cctaagtgac aacatgtcag agggtagtga 4860
tgattctgga ttgcatgggg ctcggccagt tccacaagaa tctagcagaa aaaatgcaaa 4920
ggaagccttg gcagtcaaag cggctaaggg agattttgtt tgtatcttct gtgatcgttc 4980
tttcagaaag ggaaaagatt acagcaaaca cctcaatcgc catttggtta atgtgtacta 5040
tcttgaagaa gcagctcaag ggcaggagta aagctgaatc taagtcgact taagaaccgc 5100
tcgaggccgg caaggccgga tccagacatg ataagataca ttgatgagtt tggacaaacc 5160
acaactagaa tgcagtgaaa aaaatgcttt atttgtgaaa tttgtgatgc tattgcttta 5220
tttgtaacca ttataagctg caataaacaa gttaacaaca acaattgcat tcattttatg 5280
tttcaggttc agggggaggt gtgggaggtt ttttaaagca agtaaaacct ctacaaatgt 5340
ggtatggctg attatgatct cattcatcct tttctcctcg tccctccttc attcattcat 5400
agccccccgc cctgcccgct tcagcatttc attcattcat tcattcattc atttcccgga 5460
gctccgctag cgcacacccc ttcagccgaa ggccccagcg cgcaggcgca ggccgggaga 5520
ggcaggcacc ctccaatcgt cgggcgtcct tcctcctccg ggcggccgcc cgcttcccca 5580
tgaatgaaca ttgacgtcaa tggggcgggg cgcgcccacg tgaccccgcg cgctcccctt 5640
tataaggcgg tggaggcgcg ggcgctgtcc agcgtgctga agccggagcg agctagccgc 5700
ccggagccgc gccgacccag ctgagcccag cccacgggac gccagacctc gaccgtcgct 5760
cctaccccgg ccaccgctcg gagccgaggc ggacgcgtcc cgatcttccc ctgtccccac 5820
cctgccccga ccctcctctc cacctctcgc gtcgtgacac cagctggtaa atactccgct 5880
gttcgtccct caaaccctcg gcagccagcc gtgggcgtga gggagggttc tctctcctct 5940
cgatgggggt gttgcaaaca cagcggggag ccccctggta agggtccccg gtaaacgggg 6000
gagtcgcagc tttttctctt gctgctgaag tcgcccacgc accatccggg gagtcctacg 6060
gggagggagc agagattttt ttttccccca tattgctgct gcttagtacg tgggcgatgg 6120
cagtgagatg gctcagggaa ggggccgagg aggccctggg taagcgaggg cttcgggggt 6180
tattttccca tttacacggc tccagagatc ggcacaacat cttcctcctt tgctcctaaa 6240
cgttcctctt ctgggtaagg tttgggggat cagggaagcc ccgggtttcc tgctgaaagg 6300
tgggggaagg gaacgtagac ctagagaggg gaattcttac agaaatcctc tttttttggt 6360
cccttctatt tttcagtctc cggcagcctc ttggtcatgg tgagcaaggg cgaggagctg 6420
ttcaccgggg tggtgcccat cctggtcgag ctggacggcg acgtaaacgg ccacaagttc 6480
agcgtgtccg gcgagggcga gggcgatgcc acctacggca agctgaccct gaagttcatc 6540
tgcaccaccg gcaagctgcc cgtgccctgg cccaccctcg tgaccaccct gacctacggc 6600
gtgcagtgct tcagccgcta ccccgaccac atgaagcagc acgacttctt caagtccgcc 6660
atgcccgaag gctacgtcca ggagcgcacc atcttcttca aggacgacgg caactacaag 6720
acccgcgccg aggtgaagtt cgagggcgac accctggtga accgcatcga gctgaagggc 6780
atcgacttca aggaggacgg caacatcctg gggcacaagc tggagtacaa ctacaacagc 6840
cacaacgtct atatcatggc cgacaagcag aagaacggca tcaaggtgaa cttcaagatc 6900
cgccacaaca tcgaggacgg cagcgtgcag ctcgccgacc actaccagca gaacaccccc 6960
atcggcgacg gccccgtgct gctgcccgac aaccactacc tgagcaccca gtccgccctg 7020
agcaaagacc ccaacgagaa gcgcgatcac atggtcctgc tggagttcgt gaccgccgcc 7080
gggatcactc tcggcatgga cgagctgtac aagtaaacgc gtgaattcac tcctcaggtg 7140
caggctgcct atcagaaggt ggtggctggt gtggccaatg ccctggctca caaataccac 7200
tgagatcttt ttccctctgc caaaaattat ggggacatca tgaagcccct tgagcatctg 7260
acttctggct aataaaggaa atttattttc attgcaatag tgtgttggaa ttttttgtgt 7320
ctctcactcg gaaggacata tgggagggca aatcatttaa aacatcagaa tgagtatttg 7380
gtttagagtt tggcaacata tgcccatatg ctggctgcca tgaacaaagg ttggctataa 7440
agaggtcatc agtatatgaa acagccccct gctgtccatt ccttattcca tagaaaagcc 7500
ttgacttgag gttagatttt ttttatattt tgttttgtgt tatttttttc tttaacatcc 7560
ctaaaatttt ccttacatgt tttactagcc agatttttcc tcctctcctg actactccca 7620
gtcatagctg tccctcttct cttatggaga tccctcgacc tgcagcccaa gcttggcgta 7680
atcatggtca tagctgtttc ctg 7703
<210> 2
<211> 52
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(52)
<223>primer CIA-P1
<400> 2
gtaaaacgac ggccagtgaa ttcgacattg attattgact agttattaat ag 52
<210> 3
<211> 42
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(42)
<223>primer CIA-P2
<400> 3
gccaagcttg ggctgcaggt cgagggatct ccataagaga ag 42
<210> 4
<211> 28
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(28)
<223>primer target-p-1
<400> 4
gtctagactc cctgatcgcc tatagatc 28
<210> 5
<211> 28
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(28)
<223>primer target-p-2
<400> 5
cggtacccat gaagaaagca ggtgtggg 28
<210> 6
<211> 1361
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(1361)
<223>target DNA sequence
<400> 6
catgaagaaa gcaggtgtgg gtcctggacc aatagccctc ctgaggtctg tcctcaggga 60
ccttcccctg tgacttgtga ctgctgggat caggtcccat caccgccgta atcaaggtga 120
taaatctgtc cttcatttta acaggtgctt tacaaaagag taagtgctgg cacacagggc 180
ccaggctggg tcggcccatg attgtggaag gtgcttccca gtaatgagac agggcacatt 240
tctagctggg gcttggaacc ctcagtgaga caagaaatct cagaccccac ccttcacccc 300
ttctccacct gagctcttcc tcctccacat cacggcagcg accacagctc cagtgatcac 360
agctccaagg agaaccaggc cagcaatgat gcccacgatg gggatggtgg gctgggaaga 420
cagctctggg aaaagagggg aaggtgaggg gccctgaccc tgctaaaggt ctccagagag 480
gctcctgctt tccctaagag acatgacacc cccatctccc tccttacccc atctcagggt 540
gaggggcttg ggcagaccct catgctgcac atggcaggtg tatctctgct cctctccaga 600
aggcaccacc acagccgccc acttctggaa ggttccatcc cctgcaggcc tggtctccac 660
gagctccgtg tcctgggtct ggtcctcccc atcccgctgc caggtcagtg tgatctccgc 720
agggtagaag cccagggccc agcacctcag ggtggcctca tggtcagaga tggggtggtg 780
ggtcatatgt gtcttggggg ggtctgacgg gaagagtcag aaaattcagg cattttgcat 840
ctgtcatggg acactccacc agcacgcatg tggccatctt gagaatggac aggacacccg 900
ggatggggaa gagagcacag aacccagaca ccagcctgga cacaggcacc tgggataatc 960
ttctattccc tgagaaggga acagcgactt ctggtcctga cctgagtgga ggctgagaga 1020
ctcagaagtg ctggactcag acccccacac acattgagtg tgaagcagag aacaaggcct 1080
gagaggaaaa gtcacgggcc caaggctgct gccggtgtca aagggaacca ctcatcagta 1140
ttcgagggat cgtcttcccg tcactccttc agagatttta tcccttaatt gtgtcagaga 1200
gcagggcgga acctcagagt cactctctgg tacaggatct ggaaacccag gaggattcct 1260
ctccctcagg accagaggga gggtgatatt ctagtgttgg tcccaattgt ctcccctcct 1320
tgtgggaggc cagcccggga gatctatagg cgatcaggga g 1361
<210> 7
<211> 27
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(27)
<223>primer target-1-p-1
<400> 7
cggtaccgca gactcagttc tcattcc 27
<210> 8
<211> 27
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(27)
<223>primer target-1-p-2
<400> 8
gtctagagcc tgtgtggatg ctgagtg 27
<210> 9
<211> 1500
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> misc_feature
<222> (1)..(1500)
<223>target-1 sequence
<400> 9
gcagactcag ttctcattcc caatgggtgt cgggtttcta gagaagccaa tcagcgtcgc 60
cacgactccc gactataaag tccccatccg gactcaagaa gttctcagga ctcagaggct 120
gggatcatgg tagatggaac cctcctttta ctcctctcgg aggccctggc ccttacccag 180
acctgggcgg gtgagtgcgg ggtcgggatg gaaacggcct ctaccgggag tagagagggg 240
ccggcccggc gggggcgaag gactcgggga gccgcgccgg gaggagggtc gggccgatct 300
cagcccctcc tcgcccccag gctcccactc cttgaagtat ttccacactt ccgtgtcccg 360
gcccggccgc ggggagcccc gcttcatctc tgtgggctac gtggacgaca cccagttcgt 420
gcgcttcgac aacgacgccg cgagtccgag gatggtgccg cgggcgccgt ggatggagca 480
ggaggggtca gagtattggg accgggagac acggagcgcc agggacaccg cacagatttt 540
ccgagtgaat ctgcggacgc tgcgcggcta ctacaatcag agcgaggccg gtgagtgacc 600
ccggccaggg gagcaggtca cgacccctcc ccatccccca cggacggcgc gggtcccctc 660
gaatcttcgg gtcccagatt caccccaagg ctgcggaacc cgcccagacc ctagaccggg 720
gagagtctca ggcgccttta cccggttctt tttcagttta ggccaaaatg cccacagggt 780
ggtggcgacg ggggcggggc ttggtgggcg ggactgacta aggggcgggg ccagggtctc 840
acaccctgca gtggatgcat ggctgcgagc tggggcccga cgggcgcttc ctccgcgggt 900
atgaacagtt cgcctacgac ggcaaggatt atctcaccct gaatgaggac ctgcgctcct 960
ggaccgcggt ggacacggcg gctcagatct ccgagcaaaa gtcaaatgat gcctctgagg 1020
cggagcacca gagagcctac ctggaagaca catgcgtgga gtggctccac aaatacctgg 1080
agaaggggaa ggagacgctg cttcacctgg gtaagagggt ccacagggct actctcccat 1140
ctccttcttg ggctaggact gtgcccacag ctgacagacc tcaaacagta gaagaaacag 1200
ggatggaggc cagaatacca ctcctccctt ggatcaggag agggagctgt cacctgaggt 1260
acaggagatc ctataccaca gagtgactct cttaaagggc cagacctctc tcaggggcaa 1320
ttaaggaatc tagtctcgct ggagattcca tccttcagat gaactgatga gcagttctct 1380
ttgactccca gtattaggaa tcacggggga gtttctctcg tgcctgattc tcagccccac 1440
accaagagtt tttggaggtc tgactccagc ttttctcagt cactcagcat ccacacaggc 1500
<210> 10
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNA12b-p-01
<400> 10
gtggaaagga cgaaacaccg cgtggagacc aggcctgcag 40
<210> 11
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNA12b-p-02
<400> 11
gctatttcta gctctaaaac ctgcaggcct ggtctccacg 40
<210> 12
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNAa-p-01
<400> 12
gtggaaagga cgaaacaccg ttacaagtaa gacctactcc 40
<210> 13
<211> 40
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(40)
<223>primer gRNAa-p-02
<400> 13
gctatttcta gctctaaaac ggagtaggtc ttacttgtaa 40
<210> 14
<211> 19
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(19)
<223>primer JD-p-1
<400> 14
ggtgccctcc atgtacagc 19
<210> 15
<211> 20
<212> DNA
<213>artificial sequence (Artificial Sequence)
<220>
<221> primer_bind
<222> (1)..(20)
<223>primer JD-p-2
<400> 15
ctgcgccgtt acagatccaa 20
Claims (17)
1. a kind of Genetic elements for generating frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene, special
Sign is, the Genetic elements include the promoter effectively connected, the first reporter gene, REST gene, SV40pA gene, S heavy
Silent son, the second reporter gene and terminator, wherein can be inserted between the promoter and the first reporter gene by cutting mesh
DNA sequence dna is marked, first reporter gene is different from second reporter gene, and the expression of the REST gene is able to suppress institute
State the expression of the second reporter gene behind S silencer.
2. Genetic elements according to claim 1, which is characterized in that the Genetic elements further include the enhancing effectively connected
Son.
3. Genetic elements according to claim 2, which is characterized in that the enhancer is cmv enhancer.
4. Genetic elements according to claim 1, which is characterized in that first reporter gene is red fluorescent protein base
Cause, second reporter gene are green fluorescence protein gene.
5. Genetic elements according to claim 1, which is characterized in that the promoter is EF1 promoter, the terminator
For beta-globin polyadenylic acid.
6. Genetic elements according to claim 1, which is characterized in that the Genetic elements contain double enzyme site, described
Double enzyme site be located at the promoter and it is described first report between, it is described can be connected to by cutting target dna sequence it is described
Between double enzyme site.
7. Genetic elements according to claim 6, which is characterized in that the double enzyme site is Xba I and Kpn I digestion
Site.
8. Genetic elements according to claim 1, which is characterized in that the REST gene and the S silencer amplification in
Source of people H9 cell line.
9. Genetic elements according to claim 1, which is characterized in that the Genetic elements have such as SEQ ID NO:1 institute
The nucleotide sequence shown.
10. a kind of carrier for generating frameshift mutation for detecting CRISPR/Cas9 gene editing system cutting gene, feature exist
In the carrier includes Genetic elements as claimed in any one of claims 1-9 wherein.
11. carrier according to claim 10, which is characterized in that the carrier be pUC serial carrier, pEASY,
PBlueScriptII or pBR322.
12. a kind of host cell, which is characterized in that including as described in claim 10 or 11 for detecting CRISPR/Cas9
Gene editing system cuts the carrier that gene generates frameshift mutation.
13. host cell according to claim 12, which is characterized in that the host cell is Escherichia coli.
14. a kind of method that detection CRISPR/Cas9 gene editing system cutting gene generates frameshift mutation, which is characterized in that
Frameshift mutation is generated for detecting CRISPR/Cas9 gene editing system cutting gene using as described in claim 10 or 11
Carrier detected.
15. according to the method for claim 14, which comprises the following steps:
Carrier as described in claim 10 or 11 is inserted by cutting target dna sequence, then transfects into cell line by S1,
It is transferred to the carrier for being mounted with gRNA simultaneously, the carrier for being mounted with gRNA also includes the DNA sequence dna for expressing Cas9 albumen;
S2 observes the expression of the first reporter gene and the second reporter gene, is reported according to first reporter gene and second
The expression for accusing gene judges whether gRNA produces frameshift mutation to the editor of target dna sequence.
16. according to the method for claim 15, which is characterized in that further include: when the second reporter gene normal expression
When, it is judged as that CRISPR/Cas9 gene editing system cutting gene produces frameshift mutation, and expand the target dna sequence
It is sequenced.
17. according to the method for claim 15, which is characterized in that the cell line is HEK293 cell line.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811320658.5A CN109371167A (en) | 2018-11-07 | 2018-11-07 | Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811320658.5A CN109371167A (en) | 2018-11-07 | 2018-11-07 | Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109371167A true CN109371167A (en) | 2019-02-22 |
Family
ID=65384303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811320658.5A Pending CN109371167A (en) | 2018-11-07 | 2018-11-07 | Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109371167A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110656123A (en) * | 2019-10-12 | 2020-01-07 | 中国农业大学 | Method for screening sgRNA high-efficiency action target based on CRISPR-Cas13d system and application |
| CN111471744A (en) * | 2020-05-14 | 2020-07-31 | 重庆英茂盛业生物科技有限公司 | Method for detecting gene editing target point cutting efficiency |
| WO2025071493A1 (en) * | 2023-09-29 | 2025-04-03 | Agency For Science, Technology And Research | Dna construct and nucleic acid compound tools |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105647968A (en) * | 2016-02-02 | 2016-06-08 | 浙江大学 | Fast CRISPR-Cas9 working efficiency testing system and application thereof |
| US20160304872A1 (en) * | 2015-04-16 | 2016-10-20 | California Institute Of Technology | Fractional regulation of transcription |
| CN106636154A (en) * | 2015-10-30 | 2017-05-10 | 中国科学院上海生命科学研究院 | Efficient sgRNA screening system and efficient sgRNA screening method |
-
2018
- 2018-11-07 CN CN201811320658.5A patent/CN109371167A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160304872A1 (en) * | 2015-04-16 | 2016-10-20 | California Institute Of Technology | Fractional regulation of transcription |
| CN106636154A (en) * | 2015-10-30 | 2017-05-10 | 中国科学院上海生命科学研究院 | Efficient sgRNA screening system and efficient sgRNA screening method |
| CN105647968A (en) * | 2016-02-02 | 2016-06-08 | 浙江大学 | Fast CRISPR-Cas9 working efficiency testing system and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| PETER EISENHUT,ET AL.: "A CRISPR/Cas9 based engineering strategy for overexpression of multiple genes in Chinese hamster ovary cells", 《METABOLIC ENGINEERING》 * |
| 刘庆斌等: "不止是沉默-神经元限制性沉默因子及其作用元件的研究进展", 《生理科学进展》 * |
| 陈妍等: "负调控元件-沉默子", 《遗传》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110656123A (en) * | 2019-10-12 | 2020-01-07 | 中国农业大学 | Method for screening sgRNA high-efficiency action target based on CRISPR-Cas13d system and application |
| CN110656123B (en) * | 2019-10-12 | 2021-07-13 | 中国农业大学 | Screening method and application of sgRNA high-efficiency target based on CRISPR-Cas13d system |
| CN111471744A (en) * | 2020-05-14 | 2020-07-31 | 重庆英茂盛业生物科技有限公司 | Method for detecting gene editing target point cutting efficiency |
| WO2025071493A1 (en) * | 2023-09-29 | 2025-04-03 | Agency For Science, Technology And Research | Dna construct and nucleic acid compound tools |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108441519A (en) | The method that homologous remediation efficiency is improved in CRISPR/CAS9 gene editings | |
| WO2015100929A1 (en) | Method for constructing eukaryotic gene knockout library by using crispr/cas9 system | |
| KR102365484B1 (en) | Improved recombinant protein expression using a hybrid chef1 promoter | |
| CN110295149B (en) | A mutant strain type 3 duck hepatitis A virus CH-P60-117C strain and construction method | |
| CN116209674A (en) | KRAB fusion repressors and methods and compositions for repressing gene expression | |
| CN109371167A (en) | Genetic elements and the application of frameshift mutation are generated for detecting CRISPR/Cas9 gene editing system cutting gene | |
| KR20060123413A (en) | Expression system using mammalian β actin promoter | |
| CN101260408B (en) | Construction method and application of two-color fluorescence report carrier | |
| CN109321571A (en) | A method of utilizing CRISPR/Cas9 preparation and reorganization porcine pseudorabies virus | |
| CN112029736B (en) | Recombinant pseudorabies virus live vaccine for preventing African swine fever and preparation method thereof | |
| CN112961219B (en) | Recombinant adeno-associated virus, its mutant and its construction method and application | |
| CN109055375B (en) | Method for activating gene expression by CRISPR (clustered regularly interspaced short palindromic repeats) auxiliary trans-enhancer and application of method | |
| CN101121939B (en) | Universal green fluorescence protein fusion target gene expression vector for siRNA screening system | |
| CN114350615B (en) | STAT2 gene deletion cell strain and preparation method and application thereof | |
| CN101705246B (en) | Lentiviral gene transfer vector, preparation method and application thereof | |
| CN114395017B (en) | Preparation method and application of SARS-CoV-2 virus-like particle | |
| CN114369619A (en) | Reporter vector and vector system for gene knockout and application | |
| CN110295180B (en) | Type 3 duck hepatitis A virus mutant gene ISA-A117C-C4334A and construction method thereof | |
| CN110684781B (en) | A kind of type 3 duck hepatitis A virus mutant gene ISA-A117C-T1142A and construction method | |
| KR102427400B1 (en) | Establishment of a major allergen, Fel d 1 targeted feline cell line | |
| CN104195153A (en) | Bicistronic co-expression gene transfer bodyand preparation method | |
| CN110564765B (en) | Homologous recombination vector and recombinant cell for expressing eGFP, and preparation method and application thereof | |
| CN102994550A (en) | Method for expressing exogenous gene in animal cell or animal tissue | |
| CN110283835B (en) | Type 3 duck hepatitis A virus mutant gene ISA-T1142A-C4334A and construction method | |
| CN103131709A (en) | Ribonucleic acid (RNA) interference fragment of zinc finger-x (zfx) gene and application of RNA interference fragment in mouse sex control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |